Epsilon M&A Deal Report - Lichtwer Pharma
Transaction Multiples for the Valuation of Private Companies
Private Group led by Lichtwer Pharma Management / Lichtwer Pharma
No EMAT :
16334
Announced Date :
01/03/2004
Type :
MBO (Management Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by Lichtwer Pharma Management
Target :
Lichtwer Pharma
Country :
Germany
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Food Producers > Food & Beverage Industry > Food Complements
Business Description :
Produces natural medicines for the central nervous system , gastro-enterology, the cardio-vascular system and dermatology > Products: garlic-based Kwai, Ameu 500mg (Omega-3 fatty acid), Hepar-SL...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
- Number of EMAT Reports / sub-sector « Food Complements » = 123
| Date | Acquirer | Target | Country | Multiples | See details |
| 19/11/2004 | Diageo | Ursus Vodka Holding | Netherlands | * | 16249 |
| 19/11/2004 | LGR Holding | Italaquae | Italy | * | 16248 |
Source: Epsilon Research / EMAT
